Newmain Human Dermatech Funds Cuts MSBIO Stake to 8.22%
Newmain Human Dermatech Funds reduced its stake in MSBIO to 8.22%.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Newmain Human Dermatech Funds reduced its stake in MSBIO to 8.22%.